The iBridge Network is generating excitement from universities, researchers, entrepreneurs, and industry...
"The iBridge Network nicely embodies the ideals of a well-designed, non-profit mechanism for aggregating, searching, and disseminating innovations from multiple research institutions. Through its Web site, it has shown a way for technology transfer professionals to substantially reduce the information and transaction barriers between dispersed innovators and end-users, making research innovations more broadly available."
Patrick Jones, Ph.D. Director, Office of Technology Transfer University of Arizona
"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Through the Network, relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. The spirit of the Network’s collaboration is sure to be beneficial and exciting to all the parties involved and lead to many new opportunities."
Alan Thomas, Director, UChicagoTech
"Our economy and our standard of living are inextricably intertwined with university innovations. Unfortunately, our country’s revenue-focused, short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs beyond university walls. The iBridge Network and Web site helps break down these barriers by providing low transaction costs, and a direct link between these parties that potentially will lead to ground breaking relationships and technologies, spurring revenue and fueling our economy."
Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.
"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs and researchers certainly will stimulate innovation and fuel new ventures. I look forward to tapping into the Network, building relationships, and accessing the great minds and work of university researchers. Who knows what we’ll find?"
William Garner, M.D., MPH CEO of Urigen, N.A., Inc.
"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."
Dr. Jörg Knäblein, Technology Scouting, Bayer Schering Pharma AG
"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."
Linda L. Restifo, M.D., Ph.D. Associate Professor, Neurobiology, Neurology, and BIO5, University of Arizona
"As a life science merchant bank, Raphael Capital Partners was looking for exciting technology with large market potential and a clear go-to-market strategy. We found tremendous value and benefit in using the iBridge Network to broaden our access to people we never would have been able to previously connect with, and more easily find and filter research, ideas and innovations of interest to our business. A perfect example is our portfolio company, Emunamedica LLC, and its recent licensing agreement with Drexel University for novel non-invasive wound diagnostics."
David Kolb, CEO and chairman of the board, Emunamedica LLC.
"iBridge is a great resource for entrepreneurs who are looking for technologies to license. Many premiere universities including Michigan, Columbia, MIT, Penn, and Harvard, participate in the iBridge program."
Martin Lehr, Osage University Partners
"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."
Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester
